FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103765008> ?p ?o ?g. }

• W2103765008 endingPage "1618" @default.
• W2103765008 startingPage "1611" @default.
• W2103765008 abstract "Women with acute myocardial infarction (AMI) undergoing primary angioplasty have higher rates of morbidity and mortality than do men. Whether contemporary interventional treatment strategies have improved outcomes for women compared with men is unknown.In the CADILLAC trial, 2082 patients (27% women) with AMI within 12 hours of symptom onset were randomized to balloon angioplasty (PTCA; n=518), PTCA+abciximab (n=528), stenting (n=512), and stenting+abciximab (n=524). As compared with men, women had a lower body surface area; had a greater prevalence of diabetes, hypertension, and hyperlipidemia; experienced significant delays to treatment; and had better baseline and final TIMI grade 3 flows. Unadjusted 1-year event rates were higher for women, including death (7.6% versus 3.0%, P<0.001), ischemic target-vessel revascularization (TVR; 16.7% versus 12.1%, P=0.006), and major adverse cardiac events (MACE; 23.9% versus 15.3%, P<0.001). Female gender was an independent predictor of MACE and bleeding complications, although comorbid risk factors and body surface area but not gender predicted 1-year death. For women, primary stenting resulted in a reduction in 1-year MACE from 28.1% to 19.1% (P=0.01) and in ischemic TVR from 20.4% to 10.8% (P=0.002) compared with PTCA. The addition of abciximab to primary stenting significantly reduced the 30-day ischemic TVR without increasing bleeding or stroke rates.The higher mortality rate in women compared with men after interventional treatment for AMI may be explained by differences in body size and clinical risk factors, although female gender remains an important independent determinant of overall adverse outcomes. For women in the CADILLAC trial, the addition of abciximab reduced 30-day TVR without increasing bleeding risk, and primary stenting reduced 1-year TVR and MACE rates compared with PTCA." @default.
• W2103765008 created "2016-06-24" @default.
• W2103765008 creator A5005869814 @default.
• W2103765008 creator A5009867399 @default.
• W2103765008 creator A5014043242 @default.
• W2103765008 creator A5014857861 @default.
• W2103765008 creator A5016139987 @default.
• W2103765008 creator A5021992802 @default.
• W2103765008 creator A5028629867 @default.
• W2103765008 creator A5038506755 @default.
• W2103765008 creator A5039632207 @default.
• W2103765008 creator A5039649958 @default.
• W2103765008 creator A5041084808 @default.
• W2103765008 creator A5046629853 @default.
• W2103765008 creator A5051432538 @default.
• W2103765008 creator A5052557057 @default.
• W2103765008 creator A5057640789 @default.
• W2103765008 creator A5063816519 @default.
• W2103765008 creator A5074206747 @default.
• W2103765008 creator A5084989826 @default.
• W2103765008 date "2005-04-05" @default.
• W2103765008 modified "2023-10-13" @default.
• W2103765008 title "Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction" @default.
• W2103765008 cites W100257474 @default.
• W2103765008 cites W1964129966 @default.
• W2103765008 cites W1969108431 @default.
• W2103765008 cites W1972136898 @default.
• W2103765008 cites W1982565923 @default.
• W2103765008 cites W2000376068 @default.
• W2103765008 cites W2003914847 @default.
• W2103765008 cites W2006972445 @default.
• W2103765008 cites W2029912688 @default.
• W2103765008 cites W2057754226 @default.
• W2103765008 cites W2077873014 @default.
• W2103765008 cites W2082562136 @default.
• W2103765008 cites W2086437366 @default.
• W2103765008 cites W2094031789 @default.
• W2103765008 cites W2102296549 @default.
• W2103765008 cites W2104063656 @default.
• W2103765008 cites W2111152344 @default.
• W2103765008 cites W2111432251 @default.
• W2103765008 cites W2132770205 @default.
• W2103765008 cites W2159952454 @default.
• W2103765008 cites W2164784326 @default.
• W2103765008 cites W2168195640 @default.
• W2103765008 cites W2333133657 @default.
• W2103765008 cites W2439409175 @default.
• W2103765008 cites W2568050971 @default.
• W2103765008 doi "https://doi.org/10.1161/01.cir.0000160362.55803.40" @default.
• W2103765008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15811868" @default.
• W2103765008 hasPublicationYear "2005" @default.
• W2103765008 type Work @default.
• W2103765008 sameAs 2103765008 @default.
• W2103765008 citedByCount "184" @default.
• W2103765008 countsByYear W21037650082012 @default.
• W2103765008 countsByYear W21037650082013 @default.
• W2103765008 countsByYear W21037650082014 @default.
• W2103765008 countsByYear W21037650082015 @default.
• W2103765008 countsByYear W21037650082016 @default.
• W2103765008 countsByYear W21037650082017 @default.
• W2103765008 countsByYear W21037650082018 @default.
• W2103765008 countsByYear W21037650082019 @default.
• W2103765008 countsByYear W21037650082020 @default.
• W2103765008 countsByYear W21037650082021 @default.
• W2103765008 countsByYear W21037650082022 @default.
• W2103765008 countsByYear W21037650082023 @default.
• W2103765008 crossrefType "journal-article" @default.
• W2103765008 hasAuthorship W2103765008A5005869814 @default.
• W2103765008 hasAuthorship W2103765008A5009867399 @default.
• W2103765008 hasAuthorship W2103765008A5014043242 @default.
• W2103765008 hasAuthorship W2103765008A5014857861 @default.
• W2103765008 hasAuthorship W2103765008A5016139987 @default.
• W2103765008 hasAuthorship W2103765008A5021992802 @default.
• W2103765008 hasAuthorship W2103765008A5028629867 @default.
• W2103765008 hasAuthorship W2103765008A5038506755 @default.
• W2103765008 hasAuthorship W2103765008A5039632207 @default.
• W2103765008 hasAuthorship W2103765008A5039649958 @default.
• W2103765008 hasAuthorship W2103765008A5041084808 @default.
• W2103765008 hasAuthorship W2103765008A5046629853 @default.
• W2103765008 hasAuthorship W2103765008A5051432538 @default.
• W2103765008 hasAuthorship W2103765008A5052557057 @default.
• W2103765008 hasAuthorship W2103765008A5057640789 @default.
• W2103765008 hasAuthorship W2103765008A5063816519 @default.
• W2103765008 hasAuthorship W2103765008A5074206747 @default.
• W2103765008 hasAuthorship W2103765008A5084989826 @default.
• W2103765008 hasBestOaLocation W21037650081 @default.
• W2103765008 hasConcept C126322002 @default.
• W2103765008 hasConcept C164705383 @default.
• W2103765008 hasConcept C2777871224 @default.
• W2103765008 hasConcept C2777995511 @default.
• W2103765008 hasConcept C2779464278 @default.
• W2103765008 hasConcept C2779581417 @default.
• W2103765008 hasConcept C2780326628 @default.
• W2103765008 hasConcept C2780739214 @default.
• W2103765008 hasConcept C45393284 @default.
• W2103765008 hasConcept C500558357 @default.
• W2103765008 hasConcept C71924100 @default.
• W2103765008 hasConceptScore W2103765008C126322002 @default.

• next